Clinical trial
A Prospective Natural History Study of VHL Patients With CNS Hemangioblastomas
NCT00005902 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Natural History Study of VHL Patients With CNS Hemangioblastomas
- Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- February 15, 2001
- Completion date
- Not reported
- Enrollment
- 250 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemangioblastoma, hippel lindau disease